Gracell Biotechnologies (GRCL) Stock Forecast

Analyst ratings, price targets, and earnings estimates.

GRCL Analyst Ratings

Hold

Consensus

Strong Buy
0
Buy
3
Hold
4
Sell
0
Strong Sell
0
43%57%

Based on 7 analysts in the past 3 months

GRCL Stock 12 Month Forecast

$0.00

▼ (0.00% Downside)
Highest Price Target
$6.00 (0.0%)
Average Price Target
$0.00 (0.0%)
Lowest Price Target
$6.00 (0.0%)

Based on 0 analysts in the last year

Recent Price Targets
66442200Price Target ($)07 Dec07 Dec08 Dec08 Dec09 Dec09 Dec10 Dec10 Dec
Recommendation Trends
Strong Buy
Buy
Hold
Sell
Strong Sell
1010886644220042534Oct 1, 2023Oct 1, 2023Nov 1, 2023Nov 1, 2023Dec 1, 2023Dec 1, 2023Jan 1, 2024Jan 1, 2024Feb 1, 2024Feb 1, 2024Mar 1, 2024Mar 1, 2024
Analyst Estimates
Revenue Estimates
High $739.75K
Average $920.00K
Low $1.04M
0 analysts
Net Income Estimates
High $-43.22M
Average $-57.24M
Low $-66.19M
0 analysts
EPS Estimates
High $-0.40
Average $-0.53
Low $-0.62
3 analysts
Latest Price Target Updates
Date Analyst Firm Price Target Price When Posted Upside
Dec 08, 2022 None H.C. Wainwright $6.00 $2.63 128.1%

Related Metrics

Explore detailed financial metrics and analysis for GRCL.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio